RhumbLine Advisers’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $474K | Buy |
|
|||||
|
2025
Q2 | $287K | Buy |
|
|||||
|
2025
Q1 | $289K | Buy |
|
|||||
|
2024
Q4 | $429K | Buy |
|
|||||
|
2024
Q3 | $278K | Buy |
|
|||||
|
2024
Q2 | $179K | Buy |
|
|||||
|
2024
Q1 | $328K | Buy |
|
|||||
|
2023
Q4 | $256K | Sell |
|
|||||
|
2023
Q3 | $218K | Buy |
|
|||||
|
2023
Q2 | $308K | Sell |
|
|||||
|
2023
Q1 | $360K | Buy |
|
|||||
|
2022
Q4 | $334K | Buy |
|
|||||
|
2022
Q3 | $351K | Buy |
|
|||||
|
2022
Q2 | $392K | Buy |
|
|||||
|
2022
Q1 | $339K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $206K | Buy |
|